ARCB vs AZN · P/E 11, $1.94B cap vs P/E 28, $288.38B cap
ArcBest Corp (ARCB) versus AstraZeneca PLC (AZN) — a side-by-side from cached financials, not a winner call.
ArcBest Corp (ARCB) common stock.
AstraZeneca PLC (AZN) common stock.
ARCB does not have a complete income-statement cache yet.
AZN does not have a complete income-statement cache yet.
ARCB currently screens at market cap $1.94B and trailing P/E 11.2. AZN currently screens at market cap $288.38B and trailing P/E 28.0.
Not investment advice. Open the ARCB and AZN stock pages for the full models.
Not investment advice.